BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34730013)

  • 1. Venous Thromboembolism in Japanese Patients With Pancreatic Cancer.
    Suzuki T; Hori R; Takeuchi K; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Fujino S
    Clin Appl Thromb Hemost; 2021; 27():10760296211051766. PubMed ID: 34730013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism in Patents With Lung Cancer.
    Suzuki T; Fujino S; Inaba S; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Aoyama T
    Clin Appl Thromb Hemost; 2020; 26():1076029620977910. PubMed ID: 33350315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
    Barrau M; Maoui K; Le Roy B; Roblin X; Mismetti P; Phelip JM; Williet N
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3447-3454. PubMed ID: 33715087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism in Japanese Patients with Gynecologic Cancer.
    Suzuki T; Tsurimoto S; Tada T; Yamamura R; Katoh H; Noji Y; Yamaguchi M; Fujino S
    Clin Appl Thromb Hemost; 2023; 29():10760296221124121. PubMed ID: 36652383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
    Jeong HT; Bae JH; Kim HG; Han J
    Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach.
    Sood D; Kuchta K; Paterakos P; Schwarz JL; Rojas A; Choi SH; Vining CC; Talamonti MS; Hogg ME
    J Surg Oncol; 2023 Mar; 127(3):413-425. PubMed ID: 36367398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
    Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
    Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
    Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Anticoagulation in Patients With Pancreatic Adenocarcinoma: A Single Tertiary Care Center Retrospective QI Project.
    Shah S; Peterson C; Liu J; Monga DK
    Anticancer Res; 2023 Jan; 43(1):137-141. PubMed ID: 36585163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
    Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity.
    Oh SY; Kim JH; Lee KW; Bang SM; Hwang JH; Oh D; Lee JS
    Thromb Res; 2008; 122(4):485-90. PubMed ID: 18234292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG).
    Mou Y; Li M; Hou S; Ren X; Tian B
    J Thromb Thrombolysis; 2019 Nov; 48(4):648-652. PubMed ID: 31250338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC).
    González Caraballo I; Martín Lozano R; Jiménez Rodríguez R; Soto Alsar J; Ortega Morán L; Martín Jiménez M; Muñoz Martín AJ
    Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38558283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.